Vir Biotechnology, Inc. (VIR)
11.30
-0.45
(-3.83%)
USD |
NASDAQ |
Oct 30, 16:00
11.46
+0.16
(+1.42%)
After-Hours: 20:00
Vir Biotechnology Market Cap : 1.912B for Oct. 30, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 30, 2026 | 1.912B |
| October 29, 2026 | 1.988B |
| October 28, 2026 | 2.018B |
| October 27, 2026 | 1.957B |
| October 26, 2026 | 1.868B |
| October 23, 2026 | 1.788B |
| October 22, 2026 | 1.765B |
| October 21, 2026 | 1.788B |
| October 20, 2026 | 1.817B |
| October 19, 2026 | 1.727B |
| October 16, 2026 | 1.685B |
| October 15, 2026 | 1.771B |
| October 14, 2026 | 1.761B |
| October 13, 2026 | 1.795B |
| October 12, 2026 | 1.912B |
| October 09, 2026 | 1.979B |
| October 08, 2026 | 1.881B |
| October 07, 2026 | 1.949B |
| October 06, 2026 | 1.963B |
| October 05, 2026 | 1.993B |
| October 02, 2026 | 1.890B |
| October 01, 2026 | 1.910B |
| September 30, 2026 | 1.891B |
| September 29, 2026 | 1.802B |
| September 28, 2026 | 1.778B |
| Date | Value |
|---|---|
| September 25, 2026 | 1.804B |
| September 24, 2026 | 1.814B |
| September 23, 2026 | 1.876B |
| September 22, 2026 | 1.946B |
| September 21, 2026 | 1.841B |
| September 18, 2026 | 1.793B |
| September 17, 2026 | 1.848B |
| September 16, 2026 | 1.780B |
| September 15, 2026 | 1.766B |
| September 14, 2026 | 1.821B |
| September 11, 2026 | 1.797B |
| September 10, 2026 | 1.790B |
| September 09, 2026 | 1.829B |
| September 08, 2026 | 1.891B |
| September 04, 2026 | 1.926B |
| September 03, 2026 | 1.937B |
| September 02, 2026 | 1.946B |
| September 01, 2026 | 1.968B |
| August 31, 2026 | 1.851B |
| August 28, 2026 | 1.832B |
| August 27, 2026 | 1.913B |
| August 26, 2026 | 1.875B |
| August 25, 2026 | 1.812B |
| August 24, 2026 | 1.677B |
| August 21, 2026 | 1.655B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Moderna, Inc. | 88.47B |
| Vaxcyte, Inc. | 8.981B |
| Caribou Biosciences, Inc. | 44.86M |
| Arrowhead Pharmaceuticals, Inc. | 8.454B |
| Oncolytics Biotech, Inc. | 53.02M |
Market Cap Related Metrics
| PS Ratio | 5.538 |
| Price to Book Value | 1.946 |
| Price | 11.30 |
| Earnings Yield | -16.47% |